Purvi M Kakadia
Overview
Explore the profile of Purvi M Kakadia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
588
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kakadia P, Fritz B, Bohlander S
Eur J Hum Genet
. 2024 Dec;
PMID: 39643662
Craniofrontonasal syndrome (CFNS) is an X-linked developmental disorder caused by loss of function variants (LOFVs) in the ephrin B1 (EFNB1) gene located on Xq13.1. In CFNS, unlike in other X-linked...
2.
Truong P, Shen S, Joshi S, Islam M, Zhong L, Raftery M, et al.
Nat Commun
. 2024 Aug;
15(1):7360.
PMID: 39198401
Hypomethylating agents (HMAs) are frontline therapies for Myelodysplastic Neoplasms (MDS) and Acute Myeloid Leukemia (AML). However, acquired resistance and treatment failure are commonplace. To address this, we perform a genome-wide...
3.
Yap P, Riley L, Kakadia P, Bohlander S, Curran B, Rahimi M, et al.
Eur J Hum Genet
. 2023 Nov;
32(1):125-129.
PMID: 37926713
ATP2B1 encodes plasma membrane calcium-transporting-ATPase1 and plays an essential role in maintaining intracellular calcium homeostasis that regulates diverse signaling pathways. Heterozygous de novo missense and truncating ATP2B1 variants are associated...
4.
Jamieson S, Tsai P, Kondratyev M, Budhani P, Liu A, Senzer N, et al.
JCI Insight
. 2023 Feb;
8(4).
PMID: 36810255
No abstract available.
5.
Schnegg-Kaufmann A, Thoms J, Sarower Bhuyan G, Hampton H, Vaughan L, Rutherford K, et al.
Blood
. 2022 Dec;
141(11):1316-1321.
PMID: 36493342
Myelodysplastic neoplasms (MDSs) and chronic myelomonocytic leukemia (CMML) are clonal disorders driven by progressively acquired somatic mutations in hematopoietic stem cells (HSCs). Hypomethylating agents (HMAs) can modify the clinical course...
6.
Britto D, He J, Misa J, Chen W, Kakadia P, Grimm L, et al.
Development
. 2022 Oct;
149(21).
PMID: 36205097
Lymphangiogenesis is a dynamic process that involves the directed migration of lymphatic endothelial cells (LECs) to form lymphatic vessels. The molecular mechanisms that underpin lymphatic vessel patterning are not fully...
7.
Desai R, Taghavi S, Chase J, Chopra M, Chien J, Browett P, et al.
Leukemia
. 2019 Dec;
34(6):1706-1710.
PMID: 31801964
No abstract available.
8.
Das A, Kakadia P, Wojcik D, Pemberton L, Browett P, Bohlander S, et al.
Blood Cancer J
. 2019 Oct;
9(10):82.
PMID: 31578317
No abstract available.
9.
Hunter F, Devaux J, Meng F, Hong C, Khan A, Tsai P, et al.
Mol Pharmacol
. 2019 Apr;
95(6):638-651.
PMID: 30979813
Evofosfamide (TH-302) is a hypoxia-activated DNA-crosslinking prodrug currently in clinical development for cancer therapy. Oxygen-sensitive activation of evofosfamide depends on one-electron reduction, yet the reductases that catalyze this process in...
10.
Leung E, Askarian-Amiri M, Singleton D, Ferraro-Peyret C, Joseph W, Finlay G, et al.
Front Oncol
. 2018 Oct;
8:425.
PMID: 30370249
Most human breast cancer cell lines currently in use were developed and are cultured under ambient (21%) oxygen conditions. While this is convenient in practical terms, higher ambient oxygen could...